Pharma and biotechnology stakeholders are already digital, so R&D organizations are looking to embrace digital to improve interactions, insights and perform with greater operational and scientific efficiency.
Digital’s Transformative Power Across R&D: Keeping pace with Stakeholder Expectations
1. Digital’s transformative power across R&D:
Keeping pace with stakeholder expectations
Accenture Life Sciences
Rethink Reshape Restructure…for better patient outcomes